Clinical trial
Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer
NCT03115593 is registered in ClinicalTrials.gov with Brugmann University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Compare the Performance of Targeted Biopsy Versus Aspiration Biopsy With a Pipette for the Diagnosis of Endometrial Cancer
- Lead sponsor
- Brugmann University Hospital
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 10, 2018
- Completion date
- March 2, 2020
- Enrollment
- 0 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
endometrial cancer